Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Correction to: Real‑world experience with dalbavancin therapy in gram‑positive skin and soft tissue infection, bone and joint infection.

Tobudic S, Forstner C, Burgmann H, Lagler H, Steininger C, Traby L, Vossen MG, Winkler S, Thalhammer F.

Infection. 2019 Nov 18. doi: 10.1007/s15010-019-01372-9. [Epub ahead of print]

PMID:
31741186
2.

Real-world experience with dalbavancin therapy in gram-positive skin and soft tissue infection, bone and joint infection.

Tobudic S, Forstner C, Burgmann H, Lagler H, Steininger C, Traby L, Vossen MG, Winkler S, Thalhammer F.

Infection. 2019 Dec;47(6):1013-1020. doi: 10.1007/s15010-019-01354-x. Epub 2019 Sep 13. Erratum in: Infection. 2019 Nov 18;:.

PMID:
31520397
3.

High-risk Mucosal Human Papillomavirus Infection in Squamous Cell Carcinoma and Bowen's Disease of the Hand.

Dorfer S, Kancz S, Birner P, Strasser K, Kirnbauer R, Petzelbauer P, Radakovic S, Harpain L, Pehamberger H, Thalhammer F, Handisurya A.

Acta Derm Venereol. 2019 Apr 1;99(4):462-463. doi: 10.2340/00015555-3115. No abstract available.

4.

Hypoalbuminemia as predictor of recurrence of Clostridium difficile infection.

Knafl D, Vossen MG, Gerges C, Lobmeyr E, Karolyi M, Wagner L, Thalhammer F.

Wien Klin Wochenschr. 2019 Feb;131(3-4):68-74. doi: 10.1007/s00508-018-1432-y. Epub 2019 Jan 7.

5.

Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis.

Kussmann M, Karer M, Obermueller M, Schmidt K, Barousch W, Moser D, Nehr M, Ramharter M, Poeppl W, Makristathis A, Winkler S, Thalhammer F, Burgmann H, Lagler H.

Emerg Microbes Infect. 2018 Dec 5;7(1):202. doi: 10.1038/s41426-018-0205-z.

6.

Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE).

Vehreschild MJGT, Taori S, Goldenberg SD, Thalhammer F, Bouza E, van Oene J, Wetherill G, Georgopali A.

Eur J Clin Microbiol Infect Dis. 2019 Jan;38(1):199. doi: 10.1007/s10096-018-3410-8.

7.

Dalbavancin Dosage.

Tobudic S, Thalhammer F.

Clin Infect Dis. 2019 Apr 24;68(9):1608. doi: 10.1093/cid/ciy941. No abstract available.

PMID:
30380040
8.

Sepsis caused by multidrug-resistant klebsiella pneumoniae infection in a 23-year-old burn patient: case report and literature review.

Freystätter C, Radtke C, Ihra G, Thalhammer F, Fochtmann-Frana A.

Ann Burns Fire Disasters. 2018 Jun 30;31(2):113-117.

9.

Multiplex PCR Unyvero i60 ITI application improves detection of low-virulent microorganisms in periprosthetic joint infections.

Sigmund IK, Windhager R, Sevelda F, Staats K, Puchner SE, Stenicka S, Thalhammer F, Holinka J.

Int Orthop. 2019 Aug;43(8):1891-1898. doi: 10.1007/s00264-018-4136-z. Epub 2018 Sep 6.

10.

Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE).

Vehreschild MJGT, Taori S, Goldenberg SD, Thalhammer F, Bouza E, van Oene J, Wetherill G, Georgopali A.

Eur J Clin Microbiol Infect Dis. 2018 Nov;37(11):2097-2106. doi: 10.1007/s10096-018-3344-1. Epub 2018 Aug 11. Erratum in: Eur J Clin Microbiol Infect Dis. 2019 Jan;38(1):199.

11.

Empirical antimicrobial treatment in haemato-/oncological patients with neutropenic sepsis.

Vossen MG, Milacek C, Thalhammer F.

ESMO Open. 2018 Jun 13;3(3):e000348. doi: 10.1136/esmoopen-2018-000348. eCollection 2018. Review.

12.

Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna.

Tobudic S, Forstner C, Burgmann H, Lagler H, Ramharter M, Steininger C, Vossen MG, Winkler S, Thalhammer F.

Clin Infect Dis. 2018 Aug 16;67(5):795-798. doi: 10.1093/cid/ciy279.

PMID:
29659732
13.

Elimination of Doripenem during Dialysis and Pharmacokinetic Evaluation of Posthemodialysis Dosing for Patients Undergoing Intermittent Renal Replacement Therapy.

Vossen MG, Ehmann L, Pferschy S, Maier-Salamon A, Haidinger M, Weiser C, Wenisch JM, Saria K, Kajahn C, Jilch S, Lemmerer R, Bécède M, Zeitlinger M, Kloft C, Jäger W, Thalhammer F.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02430-17. doi: 10.1128/AAC.02430-17. Print 2018 May.

14.

Pharmacokinetics of flucloxacillin and its metabolites in patients with renal failure: Impact on liver toxicity
.

Maier-Salamon A, Elgendy SA, Meyer B, Vossen M, Thalhammer T, Thalhammer F, Jäger W.

Int J Clin Pharmacol Ther. 2017 Sep;55(9):701-711. doi: 10.5414/CP202796.

PMID:
28737131
15.
16.

A case report of septic shock syndrome caused by S. pneumoniae in an immunocompromised patient despite of vaccination.

Singer J, Testori C, Schellongowski P, Handisurya A, Müller C, Reitter EM, Graninger W, Knöbl P, Staudinger T, Winkler S, Thalhammer F.

BMC Infect Dis. 2017 Jun 22;17(1):442. doi: 10.1186/s12879-017-2481-y.

17.

Micafungin Plasma Levels Are Not Affected by Continuous Renal Replacement Therapy: Experience in Critically Ill Patients.

Vossen MG, Knafl D, Haidinger M, Lemmerer R, Unger M, Pferschy S, Lamm W, Maier-Salamon A, Jäger W, Thalhammer F.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e02425-16. doi: 10.1128/AAC.02425-16. Print 2017 Aug.

18.

Direct sternal administration of Vancomycin and Gentamicin during closure prevents wound infection.

Andreas M, Muckenhuber M, Hutschala D, Kocher A, Thalhammer F, Vogt P, Fleck T, Laufer G.

Interact Cardiovasc Thorac Surg. 2017 Jul 1;25(1):6-11. doi: 10.1093/icvts/ivx032.

PMID:
28402472
19.

Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE).

Knafl D, Tobudic S, Cheng SC, Bellamy DR, Thalhammer F.

Eur J Clin Microbiol Infect Dis. 2017 Apr;36(4):677-680. doi: 10.1007/s10096-016-2845-z. Epub 2016 Nov 28.

20.

[Guidelines for vaccination of immunocompromised individuals].

Wiedermann U, Sitte HH, Burgmann H, Eser A, Falb P, Holzmann H, Kitchen M, Köller M, Kollaritsch H, Kundi M, Lassmann H, Mutz I, Pickl WF, Riedl E, Sibilia M, Thalhammer F, Tucek B, Zenz W, Zwiauer K.

Wien Klin Wochenschr. 2016 Aug;128 Suppl 4:337-76. doi: 10.1007/s00508-016-1033-6. Epub 2016 Jul 25. German.

PMID:
27457874
21.

Community-acquired Haemophilus influenzae pneumonia--New insights from the CAPNETZ study.

Forstner C, Rohde G, Rupp J, Schuette H, Ott SR, Hagel S, Harrison N, Thalhammer F, von Baum H, Suttorp N, Welte T, Pletz MW; CAPNETZ Study Group.

J Infect. 2016 May;72(5):554-63. doi: 10.1016/j.jinf.2016.02.010. Epub 2016 Mar 3.

PMID:
26940505
22.

Tigecycline as last resort in severe refractory Clostridium difficile infection: a case report.

Knafl D, Winhofer Y, Lötsch F, Weisshaar S, Steininger C, Burgmann H, Thalhammer F.

J Hosp Infect. 2016 Mar;92(3):296-8. doi: 10.1016/j.jhin.2015.11.010. Epub 2015 Nov 30. No abstract available.

PMID:
26810610
23.

Doripenem Treatment during Continuous Renal Replacement Therapy.

Vossen MG, Wenisch JM, Maier-Salamon A, Fritsch A, Saria K, Zuba C, Jilch S, Lemmerer R, Unger M, Jaehde U, Jäger W, Thalhammer F.

Antimicrob Agents Chemother. 2015 Dec 28;60(3):1687-94. doi: 10.1128/AAC.01801-15.

24.

Hepatosplenic Abscesses and Osteomyelitis of the Spine in an Immunocompetent Adult with Cat Scratch Disease.

Knafl D, Lötsch F, Burgmann H, Goliasch G, Poeppl W, Ramharter M, Thalhammer F, Schuster C.

Case Rep Infect Dis. 2015;2015:317260. doi: 10.1155/2015/317260. Epub 2015 Oct 21.

25.

Case report: spontaneous rupture of spleen in patient with Plasmodium ovale malaria.

Lemmerer R, Unger M, Voßen M, Forstner C, Jalili A, Starzengruber P, Werzowa J, Ramharter M, Winkler S, Thalhammer F.

Wien Klin Wochenschr. 2016 Jan;128(1-2):74-7. doi: 10.1007/s00508-015-0888-2. Epub 2015 Nov 5.

PMID:
26542132
26.

Cefazolin and linezolid penetration into sternal cancellous bone during coronary artery bypass grafting.

Andreas M, Zeitlinger M, Wisser W, Jaeger W, Maier-Salamon A, Thalhammer F, Kocher A, Hiesmayr JM, Laufer G, Hutschala D.

Eur J Cardiothorac Surg. 2015 Nov;48(5):758-64. doi: 10.1093/ejcts/ezu491. Epub 2014 Dec 18.

PMID:
25527166
27.

Single-dose pharmacokinetics of cidofovir in continuous venovenous hemofiltration.

Vossen MG, Gattringer KB, Jäger W, Kraff S, Thalhammer F.

Antimicrob Agents Chemother. 2014;58(4):1952-5. doi: 10.1128/AAC.01343-13. Epub 2014 Jan 13.

28.

Pharmacokinetics of ganciclovir during continuous venovenous hemodiafiltration in critically ill patients.

Horvatits T, Kitzberger R, Drolz A, Zauner C, Jäger W, Böhmdorfer M, Kraff S, Fritsch A, Thalhammer F, Fuhrmann V, Schenk P.

Antimicrob Agents Chemother. 2014;58(1):94-101. doi: 10.1128/AAC.00892-13. Epub 2013 Oct 21.

29.

Fatal skin and pulmonary infection caused by Hormographiella aspergillata in a leukaemic patient: case report and literature overview.

Bojic M, Willinger B, Rath T, Tobudic S, Thalhammer F, Böhm A, Mitterbauer M, Schulenburg A, Wöhrer S, Kalhs P, Rabitsch W.

Mycoses. 2013 Nov;56(6):687-9. doi: 10.1111/myc.12087. Epub 2013 May 15. Review.

PMID:
23672484
30.

[Probiotics for the prevention of antibiotic-induced diarrhea].

Eser A, Thalhammer F, Burghuber F, Högenauer C, Stockenhuber F, Wenisch C, Widhalm K, Reinisch W.

Z Gastroenterol. 2012 Oct;50(10):1089-95. doi: 10.1055/s-0032-1312950. Epub 2012 Oct 11. German.

PMID:
23059802
31.

Effects of renal replacement therapy on antimicrobial therapy.

Vossen MG, Thalhammer F.

Curr Clin Pharmacol. 2013 Feb 1;8(1):39-45. Review.

PMID:
22946871
32.

The First Case(s) of Botulism in Vienna in 21 Years: A Case Report.

Vossen MG, Gattringer KB, Wenisch J, Khalifeh N, Koreny M, Spertini V, Allerberger F, Graninger W, Kornschober C, Lagler H, Reitner A, Sycha T, Thalhammer F.

Case Rep Infect Dis. 2012;2012:438989. doi: 10.1155/2012/438989. Epub 2012 Jun 21.

33.

Multiple-dose pharmacokinetics of daptomycin during continuous venovenous haemodiafiltration.

Wenisch JM, Meyer B, Fuhrmann V, Saria K, Zuba C, Dittrich P, Thalhammer F.

J Antimicrob Chemother. 2012 Apr;67(4):977-83. doi: 10.1093/jac/dkr551. Epub 2011 Dec 29.

PMID:
22210754
34.

Gemella morbillorum bacteremia after anti-tumor necrosis factor alpha as acne inversa therapy.

Vossen MG, Gattringer KB, Khalifeh N, Koreny M, Spertini V, Mallouhi A, Willeit M, Volc-Platzer B, Asboth F, Graninger W, Thalhammer F, Lagler H.

J Clin Microbiol. 2012 Mar;50(3):1109-12. doi: 10.1128/JCM.06161-11. Epub 2011 Dec 21.

35.

Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration.

Leitner JM, Meyer B, Fuhrmann V, Saria K, Zuba C, Jäger W, Böhmdorfer M, Thalhammer F.

J Antimicrob Chemother. 2011 Apr;66(4):880-4. doi: 10.1093/jac/dkq545. Epub 2011 Jan 22.

PMID:
21393208
36.

[Questionnaire surveying nephrologists on drug dose adjustment in patients with impaired kidney function].

Maus S, Holch C, Czock D, Thalhammer F, Keller F, Hartmann B.

Wien Klin Wochenschr. 2010 Aug;122(15-16):479-85. doi: 10.1007/s00508-010-1421-2. Epub 2010 Aug 4. German.

PMID:
20683672
37.

Pneumonia in a patient with familial Mediterranean fever successfully treated with anakinra--case report and review.

Hennig S, Bayegan K, Uffmann M, Thalhammer F, Winkler S.

Rheumatol Int. 2012 Jun;32(6):1801-4. doi: 10.1007/s00296-010-1429-y. Epub 2010 Mar 30. Review.

PMID:
20352226
38.

Hepatotoxicity of antibacterials: Pathomechanisms and clinical.

Leitner JM, Graninger W, Thalhammer F.

Infection. 2010 Feb;38(1):3-11. doi: 10.1007/s15010-009-9179-z. Epub 2010 Jan 27. Review.

PMID:
20107858
39.

Intra-cystic drug concentration of albendazole sulphoxide in patients with Echinococcus granulosus cysts.

Capan M, Keltner S, Thalhammer F, Winkler S, Jäger W, Zeitlinger M, Ramharter M.

Am J Trop Med Hyg. 2009 Oct;81(4):712-3. doi: 10.4269/ajtmh.2009.09-0234.

PMID:
19815892
40.

Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion.

Hutschala D, Kinstner C, Skhirdladze K, Thalhammer F, Müller M, Tschernko E.

Anesthesiology. 2009 Aug;111(2):356-65. doi: 10.1097/ALN.0b013e3181a97272.

PMID:
19602966
41.

[Needle-stick injuries--how common are they in reality].

Thalhammer F.

Wien Klin Wochenschr. 2008;120(15-16):458-60. doi: 10.1007/s00508-008-1027-0. German. No abstract available.

PMID:
18820847
42.

Catastrophic graft-versus-host disease after lung transplantation proven by PCR-based chimerism analysis.

Worel N, Bojic A, Binder M, Jaksch P, Mitterbauer G, Streubel B, Thalhammer F, Staudinger T, Laczika KF, Locker GJ.

Transpl Int. 2008 Nov;21(11):1098-101. doi: 10.1111/j.1432-2277.2008.00754.x. Epub 2008 Sep 1.

43.

Involvement of Mrp2 (Abcc2) in biliary excretion of moxifloxacin and its metabolites in the isolated perfused rat liver.

Ahmed S, Vo NT, Thalhammer T, Thalhammer F, Gattringer KB, Jäger W.

J Pharm Pharmacol. 2008 Jan;60(1):55-62.

PMID:
18088505
44.

Anakinra in two adolescent female patients suffering from colchicine-resistant familial Mediterranean fever: effective but risky.

Gattringer R, Lagler H, Gattringer KB, Knapp S, Burgmann H, Winkler S, Graninger W, Thalhammer F.

Eur J Clin Invest. 2007 Nov;37(11):912-4. No abstract available.

PMID:
17973784
45.

Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.

Fuhrmann V, Schenk P, Jaeger W, Miksits M, Kneidinger N, Warszawska J, Holzinger U, Kitzberger R, Thalhammer F.

J Antimicrob Chemother. 2007 Nov;60(5):1085-90. Epub 2007 Sep 13.

PMID:
17855725
46.

Single-dose pharmacokinetics of fosfomycin during continuous venovenous haemofiltration.

Gattringer R, Meyer B, Heinz G, Guttmann C, Zeitlinger M, Joukhadar C, Dittrich P, Thalhammer F.

J Antimicrob Chemother. 2006 Aug;58(2):367-71. Epub 2006 Jun 16.

PMID:
16782745
47.

Impaired target site penetration of vancomycin in diabetic patients following cardiac surgery.

Skhirtladze K, Hutschala D, Fleck T, Thalhammer F, Ehrlich M, Vukovich T, Müller M, Tschernko EM.

Antimicrob Agents Chemother. 2006 Apr;50(4):1372-5.

48.

Single-dose pharmacokinetics of cefodizime in critically ill elderly patients.

Meyer B, Traunmueller F, Bojic A, Locker G, Schmid R, Winkler S, Thalhammer F.

Int J Antimicrob Agents. 2006 Apr;27(4):335-8. Epub 2006 Mar 24.

PMID:
16563704
49.

Linezolid and continuous venovenous hemofiltration.

Meyer B, Thalhammer F.

Clin Infect Dis. 2006 Feb 1;42(3):435-6; author reply 437-8. No abstract available.

PMID:
16392097
50.

Supplemental Content

Loading ...
Support Center